The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.

Cannabis: dangerous, or dangerously misunderstood? President Trump’s executive order to downgrade marijuana from a schedule one to a schedule three drug ...

Key Takeaways A new presidential order speeds up cannabis reclassification for medical researchMarijuana would still not be legalThe change could allow more studies on cannabis and CBD FRIDAY, Dec. 19 ...

WASHINGTON (AP) — The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions ...

UCSF researchers showed that estrogen can turn on pain signals in the gut, offering new insights into conditions like ...

President Donald Trump formally signed an executive order to speed up the reclassification of marijuana as a Schedule 3 drug ...